NextCompany

Durable Medical Equipment Distributor

Durable Medical Equipment Distributor in Florida and on the West Coast

On NextCompany since September 5, 2026 (40 days)

FL area
Financial summary
Asking price
N/A
Gross revenue
$17,300,000
Cash flow (SDE)
N/A
EBITDA
$3,100,000

Figures come from the listing party and are not verified or guaranteed by NextCompany. Parts of this page are AI-generated and may contain errors. Verify everything before relying on it. See the Buyer Terms.

Business overview

This durable medical equipment distributor operates in Florida and on the West Coast. It specializes in continuous glucose monitors and supplies, primarily serving patients over age 65 with diabetes. The accredited Medicare supplier fulfills mail orders nationally and participates in other insurance carrier networks. It uses multi-channel direct-to-consumer marketing to acquire customers. The business generated $17.3M in revenue and $3.1M in EBITDA in 2025. Revenue reached $20.6M in 2024, with EBITDA of $4.8M. The principals seek an all-cash exit and offer a mutually agreeable transition. The business can relocate anywhere in the United States.

Who is a good fit for this business

  • Strategic acquirers seeking continuous glucose monitor distribution serving patients with diabetes.
  • Buyers pursuing an all-cash acquisition with an existing management team.
  • Buyers seeking relocation flexibility anywhere in the United States.

Details

Reason for selling
Principals seeking to exit the business

Frequently Asked Questions

The distributor specializes in continuous glucose monitors and related supplies. It primarily serves patients over age 65 with diabetes. Its customer base includes candidates for additional medical supply and pharmacy services.

The distributor holds Medicare supplier accreditation and participates in other insurance carrier networks. It operates as a national mail-order Medicare provider. Continuous glucose monitors qualify for coverage through most insurance and Medicare Part B's DME benefit. These products carry gross margins of more than 40%.

The business reports 2025 revenue of $17.3M and EBITDA of $3.1M. It reports 2024 revenue of $20.6M and EBITDA of $4.8M.

The principals seek an all-cash transaction. The business can remain in its current location or relocate anywhere in the United States.

The principals seek to exit the business. They express willingness to stay for a mutually agreeable transition. An existing management team runs the business.

Similar businesses